EN | RU
EN | RU

Help Support

Back

Levonorgestrel-releasing intrauterine system found effective to treat menometrorrhagia, dysmenorrhea, adenomyosis

Levonorgestrel-releasing intrauterine system  found effective to treat menometrorrhagia, dysmenorrhea, adenomyosis Levonorgestrel-releasing intrauterine system  found effective to treat menometrorrhagia, dysmenorrhea, adenomyosis
Levonorgestrel-releasing intrauterine system  found effective to treat menometrorrhagia, dysmenorrhea, adenomyosis Levonorgestrel-releasing intrauterine system  found effective to treat menometrorrhagia, dysmenorrhea, adenomyosis

What's new?

For managing patients with dysmenorrhea, menometrorrhagia, and adenomyosis, the levonorgestrel-releasing intrauterine system (LNG-IUS) therapy is effective.

A prospective cohort study demonstrated that LNG-IUS is an effective approach for the management of patients affected with dysmenorrhea, menometrorrhagia, and adenomyosis. Researchers undertook this trial to explore the efficacy of LNG-IUS as medical therapy in 28 patients having symptomatic adenomyosis (diagnosed through transvaginal ultrasonography). 


A control group consisting of 27 symptomatic patients (dysmenorrhea and menorrhagia) without a transvaginal ultrasonographic diagnosis of adenomyosis was managed in a similar way. In both  cohorts, the ultrasonographic aspects and clinical symptoms of dysmenorrhea and menometrorrhagia were examined.


During LNG-IUS insertion and six months after insertion, the recruited subjects were assessed for: the presence of myometrial cysts, menstrual blood loss, elevated uterine volume, heterogeneous myometrial texture, globulous uterine morphology, uterine symmetry, change in the junctional zone, hyperechogenic lines crossing the myometrium, dysmenorrhea, and adenomyomas.


Following six months, a considerable decline in the uterine volume was noted in both groups. In individuals suffering from adenomyosis, an improvement in the heterogeneity of myometrial texture, uterine symmetry, visibility of the junctional zone, adenomyomas, hyperechogenic lines, and presence of myometrial cysts was witnessed. A decrease in blood loss was observed in both the groups and specifically in adenomyotic patients. In all the patients, substantial improvement in pain was noted.


Thus, LNG-IUS can be considered an effective therapy for improving uterine morphology, and also managing symptoms of dysmenorrhea, menometrorrhagia, and adenomyosis.

Source:

The European Review for Medical and Pharmacological Sciences

Article:

The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomyosis: clinical and ultrasonographic reports

Authors:

F Costanzi et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ua ru
Try: